Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.

資産クラス

Equity

運用会社

Langar

設定国

US

設定日

2024年1月10日

ISIN

US84858T8633